A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke
John W. Dunne(The University of Western Australia), Barbara Singer(The University of Western Australia), Mike Hayes(Concord Repatriation General Hospital), Brian Zeman(Royal Rehabilitation Centre), Jean‐Michel Graciès(Université Paris-Est Créteil)
Cited by 60
Related Papers
Pathophysiology of spastic paresis. II: Emergence of muscle overactivity
|Muscle & Nerve|2005|499
Short-term effects of dynamic Lycra splints on upper limb in hemiplegic patients
|Archives of Physical Medicine and Rehabilitation|2000|262
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial
|The Lancet Neurology|2015|213
Traditional pharmacological treatments for spasticity part II: General and regional treatments
|Muscle & Nerve|1997|210
Botulinum Toxin Dilution and Endplate Targeting in Spasticity: A Double-Blind Controlled Study
|Archives of Physical Medicine and Rehabilitation|2009|185